Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Atsena Therapeutics, a US-based gene therapy developer, launched yesterday with an $8.2m funding round backed by University of Florida (UF). The round was led by Hatteras Venture Partners with the involvement of spinout-focused investment firm Osage University Partners and RD Fund, a vehicle for research charity Foundation Fighting Blindness, with additional participation from PBM Capital.…

The rest of this content is only accessible to Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.